Trader notes, earnings previews, Confluences, weekly digests and roundups — long-form analysis grounded in ORTEX short interest, options flow and analyst data.
Trader Note — 15017 total
GRPN enters the week after a 40% rally still trading above $22 — but the short position that absorbed that move remains almost entirely intact, and borrow availability has eased only to levels history suggests are…
Alumis Inc. heads into its June 30 quarterly earnings with short sellers rebuilding positions at pace — even as the stock climbs toward a six-week high. The sharpest signal this week is the sudden acceleration in short…
BioCryst Pharmaceuticals heads into the final week of June with a striking divergence: short interest is climbing to a one-month high while options traders have swung to their most bullish posture in at least a…
Cerus Corporation is heading into its August earnings window with short interest running at a multi-month high — even as the stock posts its best weekly gain in some time and options traders turn unmistakably…
P911 enters the final week of June with a borrowing market that has abruptly seized up — cost to borrow surged from roughly 10% to 155% in a single session, while the stock shed nearly 10% across the week. The clearest…
Hilton Grand Vacations heads into the final trading week of June with a striking disconnect between insider selling and improving short-side sentiment. The most arresting data point this week is not in the borrow…
ISDMR, the Turkish steelmaker Iskenderun Demir ve Çelik, heads into its July 24 earnings release with the lending market as loose as it has been all year — and with a peer group that spent the week going in opposite…
Eli Lilly and Company has shifted gear sharply this week, with the stock posting its strongest five-session gain in months as shorts continue to pull back — the question now is whether the move is sustainable heading…
USA Compression Partners gained 5.1% on the week to close at $26.34 — bucking a broad sell-off across its correlated peers while the short score quietly eased from a mid-week spike. The most striking feature of this…
XTB has dropped nearly 5% on the week to PLN 104.12, a soft patch that sits in contrast to a lending market almost entirely indifferent to the move. The most striking feature of XTB's positioning right now is just how…
Rezolve AI has emerged from its June 26 earnings print with short interest rebuilt, borrow costs at their highest level in months, and the stock down 11% on the week — the setup bears had been leaning into has now…
SoundHound AI closes out the week with a striking contradiction: short sellers are pressing their most aggressive position in months, yet options traders are the most bullish they have been all year. The short side of…
LATENTVIEW heads into its July 31 earnings event carrying a month of steady price erosion and a Street that has gone quiet — the question is whether the underlying analytics story still justifies a premium…
Lucid Group is sitting in a rare and uncomfortable place: short interest is rising into a borrow market that has essentially closed, and the stock still just surged 15% in a single session. The borrow picture is about…
Faeth Therapeutics is at the centre of a striking divergence this week: short sellers are rapidly covering a historically extreme position while the company's own CFO is stepping in to buy shares on the open…
Moderna has now re-rated 43% in a single month, yet the short base has not just survived the rally — it has grown through it. Short interest has climbed to 15.4% of the free float, edging up roughly 3% over the past…
MongoDB has snapped back 6.8% on Friday to $314, recovering ground after a brutal week that left it down 5.6% — and the June 30 earnings print is now the only thing that matters. The bounce is real, but the…
ROKU is caught between two opposing forces: short sellers who have rebuilt to a 2026 high and options traders who are the most bullish they have been all year. The short interest story is striking in its speed. Bears…
VOO has now completed its third options sentiment collapse of June, but this one arrived without the safety net that cushioned the previous two. The prior two PCR collapses — on June 9 and June 16 — happened while the…
Capricor Therapeutics fell 13% on Friday to $26.44, erasing the twin weekly gains that had animated two consecutive "bears losing ground" narratives — and the short position that rebuilt so aggressively last week shows…
